WebDec 31, 2024 · Med-Pharmex for a combined purchase price of £399.2 million together with ongoing investment in working capital. • Underlying diluted EPS declined (20.4)% at CER … Web3 hours ago · Dechra Pharmaceuticals has confirmed they have entered into discussions to be acquired by Swedish private equity firm EQT for £4.6bn. ... including last year’s deals to purchase Med-Pharmex, a ...
Dechra Pharmaceuticals acquired Med-Pharmex for …
WebAug 30, 2024 · Dechra Pharmaceuticals PLC on Tuesday said it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex Inc for $260.0 million. The FTSE-100 veterinary products firm said the total consideration, which is the equivalent of £221.5 million, was paid on a debt-free and cash-free basis. WebDechra is a global specialist in veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. ... In August 2024, we completed our most recent company acquisition when acquiring Med-Pharmex, Inc, a leading ... second 100 common words
Bunzl H1 profits grow, Dechra buys California-based Med-Pharmex
WebFTSE 100-listed Dechra posted a 13.8 per cent rise in revenue to £681.8million for the year to 30 June, up from £608million a year ago. ... of Med-Pharmex strategically strengthens our position ... WebAug 30, 2024 · Med-Pharmex is a leading, fully-integrated veterinary pharmaceutical manufacturer focused on developing, manufacturing, and commercializing animal health drugs. WebAug 30, 2024 · Med Pharmex Med Pharmex is a manufacturer of pharmaceutical products for the animal health market which includes companion and food producing animals. Acquiring Organization: Dechra Pharmaceuticals Dechra is an international specialist veterinary pharmaceuticals and related products business. secon cyber security revenue